Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Intervalo de año de publicación
1.
Environ Toxicol Pharmacol ; 27(2): 187-94, 2009 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21783938

RESUMEN

The SOS-chromotest in Escherichia coli is a widely used bacterial genotoxicity assay to test potential carcinogens. The aim of this work is to evaluate the genotoxic and antigenotoxic activities of essential oils obtained from aerial parts of Pituranthos chloranthus. The tested essential oils were not genotoxic towards both E. coli PQ37 and PQ35 strains. These essential oils reduced significantly Nifuroxazide and H(2)O(2)-induced genotoxicity. Essential oils showed a protective effect against damages induced by radicals, obtained from the photolysis of H(2)O(2), on DNA plasmid through free radical scavenging mechanisms. The scavenging capacity of these essential oils was also estimated by evaluating the inhibition of ABTS(+.) radical.

2.
Int J Pharm ; 190(1): 103-7, 1999 Nov 10.
Artículo en Inglés | MEDLINE | ID: mdl-10528102

RESUMEN

The physicochemical stability and the compatibility between N-acetylcysteine (1 g/5 ml), betamethasone (4 mg/1 ml) and netilmicin (100 mg/1 ml) were studied at room temperature (25+/-2 degrees C) over 1 h. During this study, drug concentrations were measured using three separate HPLC methods with UV detection at t=0, 5, 10, 20, 30, and 60 min. The pH of the mixture was determined. Degradation products of the drugs were assayed using HPLC. This study demonstrates the stability and compatibility of the mixture over 1 h at room temperature. The pinkish non-remnant coloration observed when pouring N-acetylcysteine into a recipient has no effect on the stability of the drug.


Asunto(s)
Acetilcisteína/química , Betametasona/química , Netilmicina/química , Acetilcisteína/análisis , Aerosoles/análisis , Aerosoles/química , Betametasona/análisis , Cromatografía Líquida de Alta Presión , Composición de Medicamentos , Incompatibilidad de Medicamentos , Estabilidad de Medicamentos , Concentración de Iones de Hidrógeno , Netilmicina/análisis , Factores de Tiempo
3.
Am J Clin Oncol ; 20(4): 376-80, 1997 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-9256893

RESUMEN

Small cell anaplastic carcinoma of the prostate (SCCP) is a rare entity; a literature review disclosed fewer than 150 cases. SCCP has an aggressive course, and both local and distant failure is common. The optimal treatment method has not been clearly established. We review our experience with 7 patients, with attention paid to clinical and pathological details based on a review of the histological specimens. Three patients had mixed tumors of both SCCP and adenocarcinoma, 3 had pure adenocarcinomas that recurred as small cell, and 1 had pure small cell. Our series confirms the aggressive nature of the disease, with all patients dying of their disease < or = 42 months after diagnosis. All patients progressed locally, and at least 5 later developed distant metastases. Treatment with combination chemotherapy and/or hormones resulted in short-lived responses in most patients. We recommend use of hormonal manipulation and combination chemotherapy as well as surgery and/or radiation therapy to the prostate for local control and emphasize that histologic recognition of the entity is important for proper treatment.


Asunto(s)
Carcinoma de Células Pequeñas/patología , Neoplasias de la Próstata/patología , Adenocarcinoma/patología , Adenocarcinoma/radioterapia , Adenocarcinoma/secundario , Adenocarcinoma/terapia , Anciano , Anciano de 80 o más Años , Anaplasia , Antineoplásicos Hormonales/uso terapéutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Antígeno Carcinoembrionario/análisis , Carcinoma de Células Pequeñas/radioterapia , Carcinoma de Células Pequeñas/secundario , Carcinoma de Células Pequeñas/terapia , Diagnóstico Diferencial , Progresión de la Enfermedad , Supervivencia sin Enfermedad , Resultado Fatal , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia , Neoplasias Primarias Múltiples/patología , Neoplasias Primarias Secundarias/patología , Antígeno Prostático Específico/análisis , Prostatectomía , Neoplasias de la Próstata/radioterapia , Neoplasias de la Próstata/terapia , Tasa de Supervivencia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA